Commit Biologics

Commit Biologics

Developing a novel platform technology that utilizes the complement system, a crucial component of the innate immune system, to potentially create new treatments for various cancers and autoimmune diseases.

HQ location
Ry, Denmark
Launch date
Employees
Enterprise value
$88m
Company register number
42642649
Authorizing premium user...